LeMaitre Vascular, Inc.
LMATStock
$103.03+21.35%52W
Market Cap$2.33B
P/E40.31x
Div yield1.00%
Beta0.54
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)9.69%
Price vs S&P 500 (4W)6.26%
VGM Score53.13
Market Capitalization$2.33B
P/E Ratio (Annual)40.31x
Indicated Dividend Yield (Annual)1.00%
Earnings Surprise History
Q1 260.68est. 0.67
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.00
4.00
4.00
4.00
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
LMATLeMaitre Vascular, Inc. | D | B | C | $103.03 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
LeMaitre Vascular manufactures and distributes medical devices for treating peripheral vascular disease during open surgery, with primary revenue from lower extremity and carotid product lines. Its portfolio includes angioscopes, balloon catheters, vascular grafts, vessel closure systems, and related surgical devices. The company also processes and cryopreserves human tissues for implantation.